Novo Nordisk | NVO - Stock


Novo Nordisk reported DKK42.85B in Stock for its fiscal quarter ending in March of 2025.





Stock Change Date
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
Bausch Health Companies USD 1.6B 57M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Corcept Therapeutics USD 12.87M 519K Dec/2025
Drreddys Laboratories INR 79.01B 3.41B Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Merck USD 6.44B 157M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Novo Nordisk DKK 42.85B 2B Mar/2025
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Phibro Animal Health USD 517.35M 45.57M Dec/2025
Prestige Brands USD 163.59M 4.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Zoetis USD 2.43B 35M Dec/2025